Experimental cell therapy targets hard-to-treat blood cancers
NCT ID NCT04155710
First seen Jan 05, 2026 · Last updated May 18, 2026 · Updated 23 times
Summary
This early-phase trial tested a new cell therapy called IOV-2001 in 7 people whose chronic lymphocytic leukemia or small lymphocytic lymphoma had stopped responding to standard treatments like ibrutinib. The therapy uses the patient's own immune cells, which are collected, processed, and given back along with a drug called IL-2. The main goals were to find the right dose and see if the treatment could shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allegheny Health
Pittsburgh, Pennsylvania, 15224, United States
-
Baptist Cancer Center
Memphis, Tennessee, 38120, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
-
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.